Reversal of P-Glycoprotein and Multidrug Resistance-Associated Protein 1 Mediated Multidrug Resistance in Cancer Cells by HZ08 Isomers, Tetrataisohydroquinolin Derivatives-Reference-Cited by-同舟云学术

Reversal of P-Glycoprotein and Multidrug Resistance-Associated Protein 1 Mediated Multidrug Resistance in Cancer Cells by HZ08 Isomers, Tetrataisohydroquinolin Derivatives

Published:2008 Issue:6 Volume:31 Page:1258-1264
ISSN:0918-6158
Container-title:Biological and Pharmaceutical Bulletin
language:en
Short-container-title:Biol. Pharm. Bull.

Author:

Yan Fang¹,Jiang Yi²,Li Yun-Man¹,Zhen Xia¹,Cen Juan¹,Fang Wei-Rong¹

Affiliation:

1. Department of Physiology, China Pharmaceutical University

2. Shanghai Institute of Materia Medica

Publisher

Pharmaceutical Society of Japan

Subject

Pharmaceutical Science,Pharmacology,General Medicine

Link

http://www.jstage.jst.go.jp/article/bpb/31/6/31_6_1258/_pdf

Reference42 articles.

1. Targeting multidrug resistance in cancer

2. Multidrug resistance transporters and modulation

3. Multidrug resistance in cancer: role of ATP–dependent transporters

4. Identification of the multidrug resistance-related membrane glycoprotein as an acceptor for calcium channel blockers.

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prospective pharmacological potential of cryptotanshinone in cancer therapy;Pharmacological Research - Modern Chinese Medicine;2023-12

2. Study of the Biological Activity of Alkyl Derivatives of Tetrahydroisoquinolines;Journal of Pharmaceutical Research International;2021-10-21

3. Identification of Thienopyrimidine Scaffold as an Inhibitor of the ABC Transport Protein ABCC1 (MRP1) and Related Transporters Using a Combined Virtual Screening Approach;Journal of Medicinal Chemistry;2019-03-29

4. Small-molecule inhibitors of multidrug resistance-associated protein 1 and related processes: A historic approach and recent advances;Medicinal Research Reviews;2018-05-29

5. Establishment and characterization of an oxaliplatin-resistant hepatic cancer cell line*;Oncology and Translational Medicine;2018-04